Authors
Loading...
Observational analysis showed 2'-fucosyllactose reduced amyloid-beta and improved cognitive function in AD mice, suggesting therapeutic potential.
Munni et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: